Status: Recruiting
A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284
Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-228B in healthy subjects.
Participants needed: 60
Trial details
Phase: Phase 1Age: 19+Biological sex: AllType: InterventionalSponsor: Addpharma Inc.Updated: Mar 20, 2025Locations: 1
Eligibility criteria
Body weight equal to or greater than 50kg (Female 45kg) and Body mass index (BMI... [+1]
Participation in other clinical study with an investigational drug within the 6... [+1]